Cargando…

Identification of therapeutic targets and prognostic biomarkers in cholangiocarcinoma via WGCNA

BACKGROUND: Cholangiocarcinoma (CCA) is a highly aggressive malignant tumor for which limited treatment methods and prognostic signatures are available. This study aims to identify potential therapeutic targets and prognostic biomarkers for CCA. METHODS: Based on differentially expressed genes (DEGs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Lei, Xiao, Ting, Xu, Ling, Yao, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795187/ https://www.ncbi.nlm.nih.gov/pubmed/36591499 http://dx.doi.org/10.3389/fonc.2022.977992

Ejemplares similares

Identification of Early Diagnostic and Prognostic Biomarkers via WGCNA in Stomach Adenocarcinoma
por: Tan, Ruoyue, et al.
Publicado: (2021)

Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma
por: Xu, Lin, et al.
Publicado: (2021)

Prognostic Biomarkers Identification in Esophageal Cancer Based on WGCNA and Single-Cell Analysis
por: Zhao, Wen-jun, et al.
Publicado: (2022)

Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis
por: Yu, Weina, et al.
Publicado: (2022)

Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
por: Mranda, Geofrey Mahiki, et al.
Publicado: (2022)

Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma
por: Xu, Linping, et al.
Publicado: (2022)

Identification of Therapeutic Targets and Prognostic Biomarkers Among Integrin Subunits in the Skin Cutaneous Melanoma Microenvironment
por: Nurzat, Yeltai, et al.
Publicado: (2021)

ZFAND5 Is an Independent Prognostic Biomarker of Perihilar Cholangiocarcinoma
por: Liu, Pei, et al.
Publicado: (2022)

Identification of Key Transcription Factors and Immune Infiltration Patterns Associated With Breast Cancer Prognosis Using WGCNA and Cox Regression Analysis
por: Yin, Xin, et al.
Publicado: (2021)

The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma
por: Feng, Songshan, et al.
Publicado: (2022)

Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma
por: Li, Hanyu, et al.
Publicado: (2019)

Intrahepatic cholangiocarcinoma: The role of liver transplantation, adjunctive treatments, and prognostic biomarkers
por: Connor, Ashton A., et al.
Publicado: (2022)

Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment
por: Zeng, Qingquan, et al.
Publicado: (2020)

Construction of survival-related co-expression modules and identification of potential prognostic biomarkers of osteosarcoma using WGCNA
por: Bian, Yiying, et al.
Publicado: (2022)

Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Among Kinesin Superfamily of Proteins in Pancreatic Ductal Adenocarcinoma
por: Yang, Yang, et al.
Publicado: (2021)

Identification and verification of diagnostic biomarkers in recurrent pregnancy loss via machine learning algorithm and WGCNA
por: Wei, Changqiang, et al.
Publicado: (2023)

Bile-derived exosome noncoding RNAs as potential diagnostic and prognostic biomarkers for cholangiocarcinoma
por: Pan, Yan, et al.
Publicado: (2022)

WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma
por: Yuan, Qihang, et al.
Publicado: (2021)

Construction of co‐expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma
por: Zhou, Jing, et al.
Publicado: (2021)

Identification of Latent Diagnostic Biomarkers and Biological Pathways in Dermatomyositis Based on WGCNA
por: Ouyang, Shaxi, et al.
Publicado: (2021)

Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma
por: Lu, Chenglin, et al.
Publicado: (2022)

Identification of Important Modules and Biomarkers in Breast Cancer Based on WGCNA
por: Tian, Zelin, et al.
Publicado: (2020)

Identification and Analysis of Potential Autophagy-Related Biomarkers in Endometriosis by WGCNA
por: Wang, Jing, et al.
Publicado: (2021)

Identification of Critical Modules and Biomarkers of Ulcerative Colitis by Using WGCNA
por: Yuan, Yifan, et al.
Publicado: (2023)

Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Based on Cytolytic Activity in Skin Cutaneous Melanoma
por: Zhang, Haoxue, et al.
Publicado: (2022)

Identification of Spindle and Kinetochore-Associated Family Genes as Therapeutic Targets and Prognostic Biomarkers in Pancreas Ductal Adenocarcinoma Microenvironment
por: Liu, Yi, et al.
Publicado: (2020)

Identification of Ultrasound-Sensitive Prognostic Markers of LAML and Construction of Prognostic Risk Model Based on WGCNA
por: Tian, Chuan, et al.
Publicado: (2023)

Identification and Validation of Three Autophagy-Related Long Noncoding RNAs as Prognostic Signature in Cholangiocarcinoma
por: Liu, Ya Jun, et al.
Publicado: (2021)

Oncogenic Network and Hub Genes for Natural Killer/T-Cell Lymphoma Utilizing WGCNA
por: Liu, Huijiao, et al.
Publicado: (2020)

Identification of crucial genes in abdominal aortic aneurysm by WGCNA
por: Chen, Siliang, et al.
Publicado: (2019)

Identification of CHRNB4 as a Diagnostic/Prognostic Indicator and Therapeutic Target in Human Esophageal Squamous Cell Carcinoma
por: Li, Nan, et al.
Publicado: (2020)

Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma
por: Zhang, Lu-yang, et al.
Publicado: (2019)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
por: Zhou, Xuezhi, et al.
Publicado: (2021)

Identification of feature genes and pathways for Alzheimer's disease via WGCNA and LASSO regression
por: Sun, Hongyu, et al.
Publicado: (2022)

Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs)
por: Zhai, Xinyu, et al.
Publicado: (2023)

WGCNA Identification of Genes and Pathways Involved in the Pathogenesis of Postmenopausal Osteoporosis
por: Hao, Meng-Lei, et al.
Publicado: (2021)

The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis
por: Xu, Gang, et al.
Publicado: (2019)

Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma
por: Huang, Guang-zhao, et al.
Publicado: (2019)

Identification of AGXT2, SHMT1, and ACO2 as important biomarkers of acute kidney injury by WGCNA
por: Wei, Jinshuang, et al.
Publicado: (2023)

The expression, clinical relevance, and prognostic significance of HJURP in cholangiocarcinoma
por: Yang, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7jis81vml3cch8a1hu1kf9rpl0